Liminatus Pharma Inc. (LIMN) vs Heatwurx Inc. (PCSA)
Liminatus Pharma Inc. and Heatwurx Inc. are both Biotechnology companies. Liminatus Pharma Inc. and Heatwurx Inc. are of similar size ($5.6M and $5.2M). Liminatus Pharma Inc. has negative trailing earnings, so its P/E is not meaningful; Heatwurx Inc. trades at 1.8×. Across the 8 metrics below, Liminatus Pharma Inc. leads on 4 and Heatwurx Inc. on 4.
Valuation
Profitability
| Metric | LIMN | PCSA | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 294.43% | (464.19%) | (57.72%) |
| Return on assets | (471.47%) | (262.17%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack